| Quality management system | ISO 13485:2016 | Current certificate, certification scope, issuing body, and most recent audit information | Confirm the scope covers the supplier’s actual activities and the site producing the material. Check certificate validity directly with the issuer where possible. | High |
| United States device quality requirements | FDA Quality Management System Regulation (QMSR), 21 CFR Part 820 | Documentation describing the supplier’s quality controls and how it supports customers’ supplier-control requirements | Since February 2, 2026, the QMSR applies to FDA-regulated finished-device manufacturers. Confirm which obligations apply to the supplier’s role; do not assume every raw-material supplier must hold FDA device registration. | High |
| European Union device requirements | Regulation (EU) 2017/745 (MDR) | Product specifications, traceability records, change-control process, and any device-specific conformity documentation relevant to the supplier’s role | Determine whether the supplier provides a raw material, a component, or a finished device. MDR obligations depend on the product and the economic operator’s role; a material supplier is not automatically an MDR-certified manufacturer. | High |
| Biological safety of materials | ISO 10993 series, as applicable to the finished device | Material composition and characterization data, available biological evaluation information, and test reports when applicable | Biological evaluation depends on the finished device’s nature and duration of body contact. Assess the material in its final use and processing context rather than treating a supplier test as blanket approval. | High |
| Sterile-device packaging compatibility | ISO 11607-1 and ISO 11607-2, where applicable | Packaging material specifications and information supporting seal-process development and validation | These standards address packaging systems for terminally sterilized medical devices. Confirm that the packaging materials and converting processes are suitable for the customer’s validated packaging system. | Use-dependent |
| Sterilization process controls | ISO 11135 (ethylene oxide) or ISO 11137 series (radiation), where applicable | Sterilization-process information, validation documentation, and routine monitoring records if sterilization is within the supplier’s scope | Apply the relevant standard only when the supplier performs or controls that sterilization process. Otherwise, establish material compatibility with the customer’s sterilization method. | Use-dependent |
| Microbiological controls | ISO 11737 series, where applicable | Bioburden testing methods, sampling plans, results, and laboratory details when such controls are required | Confirm the test method and limits are appropriate to the product and sterilization validation. Bioburden testing alone does not establish sterility. | Use-dependent |
| Medical face-mask material performance | ASTM F2100, when the nonwoven is intended for medical face masks | Test reports for applicable performance characteristics, such as bacterial filtration efficiency, differential pressure, sub-micron particulate filtration, and fluid resistance | Check the specified level, test methods, sample configuration, and report date. ASTM F2100 is a performance specification; a test report is not a general certification of all supplier products. | Use-dependent |
| Chemical and restricted-substance controls | Applicable requirements may include EU REACH and customer-specific substance restrictions | Material declarations, substance disclosures, and supporting test reports when required by the intended market or customer | Confirm the exact regulatory and customer requirements for the material, intended use, and destination market. Request disclosure of relevant additives, finishes, and processing aids. | High |
| Traceability and change management | Customer quality agreement and applicable QMS requirements | Lot-identification example, certificate of analysis or conformity, retention-record policy, and written change-notification procedure | Confirm that production lots can be traced to raw materials and manufacturing records, and that changes to formulation, process, site, or critical subcontractors are communicated before implementation. | High |